New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - active: hyoscine butylbromide 20 mg/ml excipient: sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 10mg - tablet - 10 mg - active: hyoscine butylbromide 10mg excipient: acacia amylodextrin calcium phosphate carnauba wax colloidal silicon dioxide ethanol macrogol 6000 maize starch povidone purified talc stearic acid sucrose tartaric acid titanium dioxide white beeswax - muscle spasm of the gastrointestinal tract.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20mg - film coated tablet - 20 mg - active: hyoscine butylbromide 20mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 85g18490 povidone purified water - for the treatment of muscle spasm of the gastrointestinal tract relief of acute stomach ache and pain due to cramps and spasms (as stated on label)

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 10 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; acacia; white beeswax; calcium hydrogen phosphate dihydrate; stearic acid; maize starch; macrogol 6000; tartaric acid; purified talc; sucrose; povidone; carnauba wax; titanium dioxide; soluble maize starch - spasm of the gastrointestinal tract

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine - unii:2z3e1of81v) - butylscopolamine bromide 20 mg in 1 ml - buscopan is indicated for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses. buscopan should not be used in impaction colics associated with ileus, or in horses with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - hyoscine butylbromide -

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim limited - hyoscine butylbromide - solution for injection - 20 mg/ml - belladonna alkaloids, semisynthetic, quaternary ammonium compounds

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - hyoscine butylbromide - solution for injection - 20 milligram(s)/millilitre - belladonna alkaloids, semisynthetic, quaternary ammonium compounds; butylscopolamine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - hyoscine butylbromide - solution for injection - 20mg/1ml